Search

Your search keyword '"Straus, David"' showing total 626 results

Search Constraints

Start Over You searched for: Author "Straus, David" Remove constraint Author: "Straus, David" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
626 results on '"Straus, David"'

Search Results

3. Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP

4. Retrospective characterization of nodal marginal zone lymphoma

5. TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

7. Growth, body composition, and survival of juvenile white bass (Morone chrysops) when dietary fish meal is partially or totally replaced by soybean meal, poultry by-product meal, an all-plant protein blend or a commercial plant-animal protein blend

10. Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF production

11. A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

13. Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

16. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era

17. Towards sustainable water disinfection with peracetic acid in aquaculture: A review.

18. Antiparasitic effects of peracetic acid on Striped Bass infested with Trichodina spp.

19. Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies

20. Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma

22. Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

23. Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma

24. Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

27. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma

29. Repeated copper sulfate treatments have no effect on growth and survival of juvenile Walleye.

30. Initial investigations into the production of triploid sunshine bass using temperature shock.

31. HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1

35. Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma

37. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

38. The Relationships between the Winter Circulation Regimes and the Northern Hemisphere 45-Day Oscillation: A Combined Regime–Oscillation Framework.

39. Molecular Basis of T Cell Inactivation by CTLA-4

41. Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma

45. Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse

46. PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study

50. Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkinʼs Lymphoma

Catalog

Books, media, physical & digital resources